GlucoTrack Inc.

NASDAQ: IGAP · Real-Time Price · USD
3.24
0.09 (2.86%)
At close: Mar 14, 2022, 5:00 AM

GlucoTrack Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Cash & Equivalents
6.06M
Short-Term Investments
n/a
Long-Term Investments
n/a
Other Long-Term Assets
51K
Receivables
n/a
Inventory
n/a
Other Current Assets
43K
Total Current Assets
6.11M
Property-Plant & Equipment
109K
Goodwill & Intangibles
n/a
Total Long-Term Assets
160K
Total Assets
6.26M
Account Payables
631K
Deferred Revenue
n/a
Short-Term Debt
23K
Other Current Liabilities
229K
Total Current Liabilities
883K
Long-Term Debt
227K
Other Long-Term Liabilities
n/a
Total Long-Term Liabilities
227K
Total Liabilities
1.11M
Total Debt
250K
Common Stock
15K
Retained Earnings
-97.47M
Comprehensive Income
-6K
Shareholders Equity
5.16M
Total Investments
n/a